M J Langman
Impact in
- Gastroenterology top 0.5%
- Gastrointestinal Bleeding Diagnosis and Treatment
- Gastroesophageal reflux and treatments
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
Papers in
-
- Gastrointestinal Bleeding Diagnosis and Treatment 11
- Gastroesophageal reflux and treatments 6
- Gastrointestinal motility and disorders 6
- Surgery 37
- Helicobacter pylori-related gastroenterology studies 23
- Gastrointestinal disorders and treatments 7
- Eosinophilic Esophagitis 6
- Co-authors
- M W DronfieldRichard DollRichard F. LoganP. LilosK W SomervilleDalia HacohenTuvia GilatDavid Henry
- Journals
- Gut (22 papers)The Lancet (10 papers)Postgraduate Medical Journal (4 papers)Alimentary Pharmacology & Therapeutics (4 papers)Drugs (3 papers)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
M J Langman
88 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 125
- Gastroenterology 831
- Pharmacology 758
- Surgery 1.5k
- Genetics 734
- Pharmacology 219
Countries citing papers authored by M J Langman
This map shows the geographic impact of M J Langman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M J Langman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M J Langman more than expected).
Fields of papers citing papers by M J Langman
This network shows the impact of papers produced by M J Langman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M J Langman. The network helps show where M J Langman may publish in the future.
Co-authors
The 25 scholars most cited alongside M J Langman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION | 2008 | 14 |
| 2 | 2007 | 29 | |
| 3 | 2000 | 1 | |
| 4 | 1995 | 432 | |
| 5 | 1991 | 15 | |
| 6 | 1990 | 4 | |
| 7 | 1987 | 273 | |
| 8 | 1986 | 41 | |
| 9 | 1985 | 32 | |
| 10 | 1985 | 254 | |
| 11 | 1985 | 43 | |
| 12 | 1984 | 165 | |
| 13 | 1984 | 20 | |
| 14 | 1980 | 53 | |
| 15 | 1980 | 122 | |
| 16 | Peptic ulcer healing : recent studies on carbenoxolone | 1978 | 11 |
| 17 | 1977 | 14 | |
| 18 | 1975 | 11 | |
| 19 | 1973 | 18 | |
| 20 | 1971 | 26 |
About M J Langman
M J Langman is a scholar working on Gastroenterology, Surgery, Hematology, Pharmacology and Biochemistry, having authored 92 papers that have together received 3.7k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (23 papers), Gastrointestinal Bleeding Diagnosis and Treatment (11 papers), Gastrointestinal disorders and treatments (7 papers), Eosinophilic Esophagitis (6 papers), Gastroesophageal reflux and treatments (6 papers), Gastrointestinal motility and disorders (6 papers), Inflammatory Bowel Disease (6 papers) and Blood groups and transfusion (6 papers). The work is most often cited by research in Gastroenterology (831 citations), Pharmacology (758 citations), Surgery (1.5k citations), Genetics (734 citations) and Pharmacology (219 citations). M J Langman has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include M W Dronfield, Richard Doll, Richard F. Logan, P. Lilos, K W Somerville, Dalia Hacohen, Tuvia Gilat, David Henry, D G Colin‐Jones and Martin Vessey. Their work appears in journals such as Gut, The Lancet, Postgraduate Medical Journal, Alimentary Pharmacology & Therapeutics and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.